GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
A

Advicenne ALDVI.PA · EUR

Health Care · Euronext Paris · 🇫🇷 France

Compare

0.64

+1.59%

Close of 9 Nov 2026, in EUR

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Price performance

Chart by TradingView, with its own licensed prices

Advicenne — daily ALDVI

No embeddable chart for this listing. TradingView's free widgets do not cover this exchange, and an unsupported symbol would render an error panel rather than a chart.

View Advicenne on TradingView ↗
Market value
€7.9m
Last close × shares
Volume
22.7k
Shares, 9 Nov 2026

About Advicenne

Its shares trade on Euronext Paris under the ticker ALDVI.PA. It has been listed since 6 December 2017. In the fiscal year to 31 December 2025, it reported revenue of €6.0m and a net loss of €9.5m. At that date it held total assets of €7.1m and shareholders' equity of −€26.4m.

Advicenne SA develops and markets pediatric drugs for the treatment of neurological diseases. The company is headquartered in Nimes, Occitanie. The company went IPO on 2017-12-06. The firm focuses on the development of paediatric friendly therapeutics for the treatment of orphan renal diseases and niche neurology indications. The Company’s medicines are developed for patients of all ages in the fields of nephrology and neurology. Its lead product includes ADV7103, which is in phase III, designed to address dRTA both in children for whom the disease is genetic as well as for adults who may have acquired the condition as a result of autoimmune disease. Apart from its lead product, the Company also develops a portfolio of products, including ADV6209, which is an oral liquid solution for moderate sedation; Likozam, which is designed to meet the unmet medical need of patients with partial and generalized chronic refractory epilepsy; Levidcen, which is used to address the unmet medical need of epileptic patients with partial onset seizures, and ADV7103 Cystinuria, among others.

Figures and description from our data supplier, not checked against the company's own report.

More about Advicenne →

Latest on Advicenne

Our reporting

We have not reported on Advicenne yet.

Next results

1 Apr 2027

Due on 1 Apr 2027.

Other Health Care listings

Scenario calculator

Try your own numbers. This is arithmetic, not a forecast.

Interactive

Gain or loss

—

Return

—

Leaves out fees, taxes and financing.

Frequently asked questions

What is Advicenne's ticker?

Advicenne trades as ALDVI.PA on Euronext Paris, under ISIN FR0013296746.

What was Advicenne's last closing price?

0.64 on 9 Nov 2026. The figure is in EUR and is never converted.

When does Advicenne next report results?

Results are expected on 1 Apr 2027, according to our data supplier.

Sources and methodology

Chart
TradingView
Close and company data
Our data supplier
News
Our reporting

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.